Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Prime Drink Group Provides Bi-Weekly MCTO Status Report

(NASDAQ:PRME) MONTREAL, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30, 2025 and August...

How does this regulatory action compare to recent similar actions within the beverage sector, and what could it mean for Prime Drink Group's competitive positioning? What are the potential risks if the company fails to meet the September 29, 2025 filing deadline, and how might that impact investor confidence? How will the extended filing deadline and MCTO affect Prime Drink Group's share liquidity and price volatility?
Symbol: PRME
Regulation
19 days ago
Read more globenewswire

LUCARA ANNOUNCES $10 MILLION DRAW FROM LIMITED SHAREHOLDER STANDBY UNDERTAKING AND RECENT NOTABLE DIAMOND RECOVERIES

(LUC) VANCOUVER, BC, Aug. 29, 2025 /CNW/ - (TSX: LUC) (BSE: LUC) (Nasdaq FNGM: LUC) PDF Version Lucara Diamond Corp. ("Lucara" or the "Company") announces the draw down of $10.0 million of the $63....

Do the drawdown and recoveries suggest any deviation from peer companies' capital allocation strategies in the diamond mining sector? What are the expected revenue and profit impacts of the recent notable diamond recoveries on the company's upcoming quarters? How will the $10 million draw on the standby undertaking affect Lucara's liquidity and future financing needs?
Symbol: LUC
Financing
19 days ago
Read more prnewswire

LUCARA ANNOUNCES $10 MILLION DRAW FROM LIMITED SHAREHOLDER STANDBY UNDERTAKING AND RECENT NOTABLE DIAMOND RECOVERIES

(LUC) VANCOUVER, BC, Aug. 29, 2025 /PRNewswire/ - (TSX: LUC) (BSE: LUC) (Nasdaq FNGM: LUC) PDF Version Lucara Diamond Corp. ("Lucara" or the "Company") announces the draw down of $10.0 million of t...

How does this financing arrangement and its terms compare to similar financing structures used by peer junior diamond explorers, and what dilution or covenant risks might arise? What does the recent notable diamond recoveries suggest about future production volumes and revenue potential? How will the $10 million draw down from the standby undertaking affect Lucara’s cash position and liquidity runway?
Symbol: LUC
Financing
19 days ago
Read more prnewswire

Avista Makes Annual Price Adjustment Requests in Washington

(AVST) Overall changes would be effective November 1, 2025 for electric and natural gas customers Overall changes would be effective November 1, 2025 for electric and natural gas customers

How does Avista's requested price increase compare to recent adjustments by other utility peers in the region, and what impact might this have on its relative valuation? What is the likelihood that Washington regulators will approve the requested price changes, and are there any known objections or legal challenges? How will the November 1 2025 rate adjustments affect Avista's projected revenue and earnings per share for FY2025‑26?
Symbol: AVST
Regulation
19 days ago
Read more globenewswire

EHC Investors Have Opportunity to Lead Encompass Health Corporation Securities Fraud Lawsuit

(NYSE:EHC) NEW YORK, Aug. 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Enc...

What is the expected timeline for resolution and how might it influence investor sentiment? What potential financial penalties and liabilities could arise from the securities fraud claims? How will the lawsuit affect EHC's short‑term stock volatility?
Symbol: EHC
Lawsuits
19 days ago
Read more prnewswire

ALZHEIMER'S ASSOCIATION WELCOMES FDA ACTION APPROVING LEQEMBI WEEKLY SUBCUTANEOUS MAINTENANCE DOSING

(NASDAQ:BIIB) CHICAGO, Aug. 29, 2025 /PRNewswire/ -- The Alzheimer's Association welcomes today's U.S. Food and Drug Administration (FDA) action to approve weekly subcutaneous maintenance dosing of...

What are the potential risks related to insurance coverage, pricing, and supply chain that could influence the long‑term profitability of Leqembi after this approval? What impact will this new dosing regimen have on Biogen's revenue forecasts and market share compared to competing Alzheimer’s therapies such as Aduhelm and donanemab? How will the FDA approval of weekly subcutaneous dosing for Leqembi affect Biogen's (BIIB) stock price and trading volume in the short term?
Symbol: BIIB
Fda approval
19 days ago
Read more prnewswire